ELF4

protein-coding

E74 like ETS transcription factor 4, the group of ETS transcription factor family

Gene summary

The protein encoded by this gene is a transcriptional activator that binds and activates the promoters of the CSF2, IL3, IL8, and PRF1 genes. The encoded protein is involved in natural killer cell development and function, innate immunity, and induction of cell cycle arrest in naive CD8+ cells. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Jan 2010]

MANE transcript

NM_001421.4

Inheritance

XL

ClinVar variants

P:8U:141B:22

Top phenotype

Autoinflammatory syndrome, familial, X-linked, Behcet-like 2

gnomAD constraint

pLI —, LoF o/e 0.31

Max pathogenic AF

—

Genomic locus

chrX:130,063,955-130,110,716

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~46.8 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

autoinflammatory syndrome, familial, X-linked, Behcet-like 2DEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0024770

Submitter: ClinGen

*ELF4* was first reported in relation to X-linked inheritance autoinflammatory syndrome, familial Behcet-like 2 in 2021 (Tyler et al., PMID: 34326534). X-linked familial Behcet-like autoinflammatory syndrome-2 is an X-linked recessive disorder characterized by inflammatory symptoms present in males within the first decade of life. Affected males most often present with oral mucosal ulceration and skin inflammation. Other variable features include gastrointestinal ulceration, arthritis, recurrent fevers, and iron deficiency anemia. ELF-4 deficiency is also known as X-linked deficiency in *ELF4* (DEX). It is characterized by mucosal inflammation and features resembling inflammatory bowel disease (IBD), in addition to the Behcet’s phenotype. *ELF4* is a transcription factor that regulates immune responses in macrophages. The loss of *ELF4* leads to hyperinflammatory response in macrophages, specifically with regard to IL-17 and TREM-1 signaling, which contributes to the phenotype. TREM-1 blockade has been shown to mitigate inflammation and intestinal pathology in ELF-4-deficient mouse models. More recently it has been shown that *ELF4* also regulates the inflammatory potential of CD4+ T cells (Bender et al, The Journal of Immunology, May 2024, https://doi.org/10.4049/jimmunol.212.supp.1259.5567). The clinical phenotype of ELF-4 deficiency includes fevers, oral and GI ulcers, abdominal pain, diarrhea, and arthritis. DEX is primarily observed in males though skewed X-chromosome inactivation and disease has been reported in females (Zhao R et al, PMID: 39976696). Seven variants (missense, nonsense, frameshift) that have been reported in nine probands in four publications (PMIDs: 34326534, 35266071, 38231408, 36823308) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by experimental evidence (e.g. animal models, expression studies) (PMIDs: 35266071, 34326534). Mouse studies including both knock-in (W250S mice; equivalent to the human W251S) and knock-out (Elf4 KO) mice showed that there was reduced perforin expression in cytotoxic T lymphocytes. Both the Elf4 KO and W250S mice indicate that the patient-derived *ELF4* variants are loss-of-function. Further, mice harboring the W230R missense variant (equivalent to the human W231R) showed significantly decreased viral clearance compared to those from WT mice. Bone marrow-derived macrophage (BMDM) from mutant mice showed similar impairment suggesting impaired ability for viral clearance. In summary, there is definitive evidence supporting the relationship between *ELF4* and X-linked inheritance autoinflammatory syndrome, familial Behcet-like 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time This classification was approved by the ClinGen PIRD GCEP on the meeting date Jne 9, 2025 (SOP Version 10.1).

autoinflammatory syndrome, familial, X-linked, Behcet-like 2STRONG

Inheritance Pattern: XL

Disease ID:MONDO:0024770

Submitter: Labcorp Genetics (formerly Invitae)

short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemiaSUPPORTIVE

Inheritance Pattern: XL

Disease ID:MONDO:0018967

Submitter: Orphanet

Clinical Genomic Database (CGD)

Autoinflammatory syndrome, familial, X-linked, Behcet-like 2XL

Manifestation: Allergy/Immunology/Infectious

Intervention: Allergy/Immunology/Infectious

Rationale: The condition involves autoinflammatory manifestations, and medical management (eg, with steroids, TNFA blockade) have been described as beneficial; The condition may involve frequent infections, and prophylactic measures and prompt and aggressive management of infections may be beneficial

Refs: 34326534; 35266071Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ELF4 variants in ClinVar

5 Conditions Cataloged
not specifiedTotal: 69
not providedTotal: 23
Autoinflammatory syndrome, familial, X-linked, Behcet-like 2Total: 11
ELF4-related disorderTotal: 10
See casesTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001421.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
12
clinvar
9
clinvar
2
clinvar
23
missense
2
clinvar
106
clinvar
10
clinvar
1
clinvar
119
nonsense
2
clinvar
1
clinvar
11
clinvar
14
start loss
0
frameshift
2
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
12
clinvar
12
Total62141193171

Highest pathogenic variant AF is 0.0000027322876

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 20 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001421.4RefSeqNP_001412.18MANE Select
ENST00000308167.10EnsemblENSP00000311280.68MANE Select
NM_001127197.2RefSeqNP_001120669.18Standard
NM_001440765.1RefSeqNP_001427694.18Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • TYROBP Causal Network

Biological Process

  • natural killer cell proliferation
  • NK T cell proliferation
  • regulation of transcription by RNA polymerase II
  • cell differentiation
  • innate immune response

Molecular Function

  • RNA polymerase II proximal promoter sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • protein binding

Cellular Component

  • nucleus
  • nucleoplasm
  • nuclear body
  • PML body

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000308167
Coding exons
8
Length
45843
Individuals with no LoFs
125740
Homozygous LoFs
1
Heterozygous LoFs
6
Defined
125747
p
0.0000278
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.172122650.7990.00002064274
Missense (PolyPhen)5592.0850.597271625
Synonymous0.6291111200.9270.00001041457
Loss of Function2.60516.30.3060.00000126264

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000760.000062rare
Latino/Admixed American0.0000360.000029rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000620.000044rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcriptional activator that binds to DNA sequences containing the consensus 5'-WGGA-3'. Transactivates promoters of the hematopoietic growth factor genes CSF2, IL3, IL8, and of the bovine lysozyme gene. Acts synergistically with RUNX1 to transactivate the IL3 promoter (By similarity). Also transactivates the PRF1 promoter in natural killer (NK) cells. Plays a role in the development and function of NK and NK T-cells and in innate immunity. Controls the proliferation and homing of CD8+ T-cells via the Kruppel-like factors KLF4 and KLF2 (By similarity). Controls cell senescence in a p53-dependent manner. Can also promote cellular transformation through inhibition of the p16 pathway. {ECO:0000250, ECO:0000269|PubMed:10207087, ECO:0000269|PubMed:14625302, ECO:0000269|PubMed:14976184, ECO:0000269|PubMed:19380490, ECO:0000269|PubMed:8895518, ECO:0000269|PubMed:9524226}.;
Disease
DISEASE: Note=A chromosomal aberration involving ELF4 has been found in a case of acute myeloid leukemia (AML). Translocation t(X;21)(q25-26;q22) with ERG. {ECO:0000269|PubMed:16303180}.;

Recessive Scores

pRec
0.0870

Intolerance Scores

LoFtool
0.359
RVIS EVS
-0.11
RVIS percentile EVS
45.26

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.632

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.